宠物糖尿病护理设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球宠物糖尿病护理设备市场规模达22亿美元，预计2034年将以6.6%的复合年增长率成长，达到42亿美元。这主要得益于宠物饲养数量的增长、兽医保健技术的进步以及动物保健支出的增加。随着宠物拥有量的不断增长，越来越多的宠物主人开始意识到管理宠物糖尿病等慢性疾病的必要性。宠物肥胖症的日益普及、宠物人口的老化以及久坐不动的生活方式导致糖尿病病例激增，从而增加了对监测和治疗解决方案的需求。随着宠物的健康和福祉成为宠物主人的首要任务，对糖尿病等慢性疾病管理的关注预计将持续扩大市场。

技术进步提高了血糖监测仪和胰岛素帮浦等设备的普及率，这些设备有助于管理宠物的糖尿病。这些创新产品的开发帮助兽医和宠物主人提供更好的护理和更有效的治疗。随着宠物糖尿病越来越普遍，尤其是在老龄或肥胖动物中，对有效管理解决方案的需求也日益增长。已开发地区可支配收入的提高也推动了这一趋势，因为这些地区的宠物主人更有可能投资先进的医疗保健设备。

市场主要分为两大板块：胰岛素输送设备和血糖监测设备。 2024年，胰岛素输送设备占最大市场份额，价值20亿美元。该板块进一步细分为胰岛素注射器和胰岛素笔，它们对于宠物糖尿病管理至关重要。鑑于宠物糖尿病通常需要终身胰岛素治疗，胰岛素输送设备对于确保有效治疗至关重要。这些设备的普及性和价格实惠巩固了其在市场上的主导地位，成为成长的关键驱动力。

宠物糖尿病照护设备市场进一步按动物类型细分，主要分为狗、猫和马。 2024年，狗类占了54.9%的市场。由于肥胖、老化和遗传因素，狗类糖尿病盛行率较高，这使得它们成为糖尿病管理设备最常见的接受者。宠物主人越来越意识到管理爱犬健康的重要性，导致血糖监测仪和胰岛素输送系统等专用设备的使用率上升。

2024年，北美宠物糖尿病护理设备市场占据41%的市场份额，这归因于多种因素，包括该地区较高的宠物拥有率以及宠物主人对宠物糖尿病管理重要性的认识不断提高。随着越来越多的人认识到主动管理宠物健康的重要性，对血糖监测仪和胰岛素输送系统等专业护理设备的需求激增。此外，北美拥有强大的兽医基础设施，许多兽医诊所和医院提供最先进的技术，用于诊断和治疗宠物糖尿病等疾病。

全球宠物糖尿病护理设备市场的主要参与者正积极运用产品创新、策略合作伙伴关係和拓展通路等策略，以增强其影响力。硕腾、默克动物保健和碧迪等公司正在加大研发投入，以推出满足宠物主人不断变化的需求的新产品。此外，i-SENS 和 TaiDoc 等公司正致力于提高糖尿病管理设备的可近性和可负担性，以满足更广泛的客户群。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 宠物糖尿病盛行率上升
    • 宠物医疗保健支出增加
    • 宠物肥胖发生率不断上升
    • 血糖监测技术进步
  • 产业陷阱与挑战
    • 与设备相关的高成本
    • 新兴国家对此议题的认识与获取管道有限
• 成长潜力分析
• 监管格局
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 报復措施
  • 对产业的影响
    • 供给侧影响（原料）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
    • 需求面影响（售价）
      • 价格传导至终端市场
      • 市占率动态
      • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按设备类型，2021 年至 2034 年

• 主要趋势
• 胰岛素输送装置
  • 胰岛素注射器
  • 胰岛素注射笔
• 血糖监测设备
  • 血糖监测仪（BGM）
  • 连续血糖监测仪（CGM）

第六章：市场估计与预测：依动物类型，2021 年至 2034 年

• 主要趋势
• 狗
• 猫
• 马匹

第七章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 兽医医院和诊所
• 居家照护环境
• 其他最终用途

第八章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• Allison Medical
• ALR Technologies
• Becton, Dickinson and Company
• Boehringer Ingelheim
• FitBark
• Henry Schein Animal Health
• Merck Animal Health
• TaiDoc
• Ulticare
• Zoetis

The Global Pet Diabetes Care Devices Market was valued at USD 2.2 billion in 2024 and is estimated to grow at a CAGR of 6.6% to reach USD 4.2 billion by 2034, driven by the increasing adoption of pets, technological advancements in veterinary healthcare, and rising expenditure on animal healthcare. As pet ownership continues to rise, more owners are becoming aware of the need for managing chronic conditions like diabetes in pets. The growing prevalence of pet obesity, the aging pet population, and sedentary lifestyles contribute to the surge in cases of diabetes, thus increasing demand for monitoring and treatment solutions. As pets' health and well-being become a top priority for owners, the focus on managing chronic conditions such as diabetes is expected to continue to expand the market.

Technological advancements have improved the availability of devices such as glucose monitors and insulin pumps, which help manage diabetes in pets. The development of these innovative products has helped veterinarians and pet owners provide better care and more effective treatments. As diabetes among pets becomes more common, especially in aging or obese animals, the demand for effective management solutions grows. This trend is supported by higher disposable income in developed regions, where pet owners are more likely to invest in advanced healthcare devices.

The market is divided into two main segments: insulin delivery devices and glucose monitoring devices. In 2024, insulin delivery devices held the largest market share, valued at USD 2 billion. This segment is further divided into insulin syringes and insulin pens, which are essential for managing diabetes in pets. Given that diabetes in pets often requires lifelong insulin therapy, insulin delivery devices are crucial for ensuring effective treatment. The widespread availability and affordability of these devices have solidified their dominance in the market, providing a key driver for growth.

The pet diabetes care devices market is further segmented by animal type, with dogs, cats, and horses being the primary categories. The dogs segment held a 54.9% share in 2024. The higher prevalence of diabetes in dogs, driven by obesity, aging, and genetic factors, makes them the most common recipients of diabetes management devices. Pet owners are increasingly aware of the importance of managing their dogs' health, leading to an uptick in the adoption of specialized devices like glucose monitors and insulin delivery systems.

North American Pet Diabetes Care Devices Market held a 41% share in 2024, attributed to several factors, including the high rate of pet ownership across the region and a growing awareness among pet owners regarding the importance of diabetes management for their pets. With more individuals recognizing the significance of proactive health management for their animals, demand for specialized care devices such as glucose monitors and insulin delivery systems has surged. Additionally, North America benefits from a robust veterinary infrastructure, with numerous veterinary clinics and hospitals offering state-of-the-art technologies for diagnosing and treating conditions like diabetes in pets.

Key players in the Global Pet Diabetes Care Devices Market are actively employing strategies like product innovation, strategic partnerships, and expanding their distribution channels to strengthen their presence. Companies like Zoetis, Merck Animal Health, and Becton, Dickinson and Company are investing in research and development to introduce new products that cater to the evolving needs of pet owners. In addition, firms such as i-SENS and TaiDoc are focusing on enhancing the accessibility and affordability of diabetes management devices to cater to a broader customer base.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of pet diabetes
    • 3.2.1.2 Increasing pet healthcare expenditure
    • 3.2.1.3 Growing incidence of obesity in pets
    • 3.2.1.4 Technological advancements in glucose monitoring
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with devices
    • 3.2.2.2 Limited awareness and access in emerging countries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Retaliatory measures
  • 3.5.2 Impact on the Industry
    • 3.5.2.1 Supply-side impact (raw materials)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (selling price)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Insulin delivery devices
  • 5.2.1 Insulin syringes
  • 5.2.2 Insulin delivery pen
• 5.3 Glucose monitoring devices
  • 5.3.1 Blood glucose monitors (BGMs)
  • 5.3.2 Continuous glucose monitors (CGMs)

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Dogs
• 6.3 Cats
• 6.4 Horses

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Veterinary hospitals and clinics
• 7.3 Homecare settings
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Allison Medical
• 9.2 ALR Technologies
• 9.3 Becton, Dickinson and Company
• 9.4 Boehringer Ingelheim
• 9.5 FitBark
• 9.6 Henry Schein Animal Health
• 9.7 Merck Animal Health
• 9.8 TaiDoc
• 9.9 Ulticare
• 9.10 Zoetis